Hollak CE - Search Results

1

Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III.

Cox-Brinkman J, van Breemen MJ, van Maldegem BT, Bour L, Donker WE, Hollak CE, Wijburg FA, Aerts JM. Cox-Brinkman J, et al. Among authors: hollak ce. J Inherit Metab Dis. 2008 Dec;31(6):745-52. doi: 10.1007/s10545-008-0873-2. Epub 2008 Oct 15. J Inherit Metab Dis. 2008. PMID: 18850301

2

[Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].

Hollak CE, Aerts JM, Goudsmit R. Hollak CE, et al. Ned Tijdschr Geneeskd. 1991 Nov 16;135(46):2162-4. Ned Tijdschr Geneeskd. 1991. PMID: 1956441 Review. Dutch. No abstract available.

3

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.

Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH. Hollak CE, et al. Lancet. 1995 Jun 10;345(8963):1474-8. doi: 10.1016/s0140-6736(95)91037-9. Lancet. 1995. PMID: 7769902 Clinical Trial.

4

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Hollak CE, van Weely S, van Oers MH, Aerts JM. Hollak CE, et al. J Clin Invest. 1994 Mar;93(3):1288-92. doi: 10.1172/JCI117084. J Clin Invest. 1994. PMID: 8132768 Free PMC article.

5

Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Aerts JM, Van Weely S, Boot R, Hollak CE, Tager JM. Aerts JM, et al. Among authors: hollak ce. J Inherit Metab Dis. 1993;16(2):288-91. doi: 10.1007/BF00710267. J Inherit Metab Dis. 1993. PMID: 8411983 Review. No abstract available.

6

Treatment of Gaucher's disease.

Hollak CE, Aerts JM, van Oers MH. Hollak CE, et al. N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567. N Engl J Med. 1993. PMID: 8479498 No abstract available.

7

[The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].

Hollak CE, van Oers MH, Maaswinkel P, Aerts JM, Goudsmit R. Hollak CE, et al. Ned Tijdschr Geneeskd. 1996 May 11;140(19):1011-3. Ned Tijdschr Geneeskd. 1996. PMID: 8684492 Review. Dutch. No abstract available.

8

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, Hollak CE, Aerts JM, Galjaard H, van Diggelen OP. Guo Y, et al. Among authors: hollak ce. J Inherit Metab Dis. 1995;18(6):717-22. doi: 10.1007/BF02436762. J Inherit Metab Dis. 1995. PMID: 8750610

9

The effect of enzyme therapy in a patient with Gaucher disease type III.

Bosman DK, Hollak CE, Aerts JM, Bakker HD. Bosman DK, et al. Among authors: hollak ce. J Inherit Metab Dis. 1996;19(5):703-4. doi: 10.1007/BF01799852. J Inherit Metab Dis. 1996. PMID: 8892032 No abstract available.

10

Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease.

Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CE, Van Oers MH, Aerts JM. Michelakakis H, et al. Among authors: hollak ce. Biochim Biophys Acta. 1996 Dec 16;1317(3):219-22. doi: 10.1016/s0925-4439(96)00056-7. Biochim Biophys Acta. 1996. PMID: 8988238 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters